Medical biotechnology industry

FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
FILE- In this March 12, 2019, file photo a handheld device of trader Sal Suarino is reflected in his glasses as he works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Thursday, March 21. (AP Photo/Richard Drew, File)
March 21, 2019 - 10:25 am
NEW YORK (AP) — U.S. stocks moved broadly higher in early trading on Wall Street Thursday as technology stocks offset declines in the banking sector. Apple rose 2.8 percent as it continues to announce new products. Olive Garden owner Darden Restaurants soared 6.4 percent after reporting earnings...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 1:43 pm
Stocks declined broadly on Wall Street Monday afternoon, knocking more than 300 points off the Dow Jones Industrial Average. Health care, technology and financial stocks took the heaviest losses. The broad sell-off came as investors waited for more details on reports that the U.S. and China are...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 12:16 pm
NEW YORK (AP) — Stocks are edging lower on Wall Street in afternoon trading as investors wait for more details on reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute. Stocks fell back in afternoon trading, erasing an early rally. The market is still...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 10:57 am
NEW YORK (AP) — Stocks are edging higher on Wall Street in morning trading following reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute. The world's two largest economies have pulled back from an immediate escalation of their damaging trade war since...
Read More
A currency trader watches computer monitors at the foreign exchange dealing room in Seoul, South Korea, Monday, March 4, 2019. Asian stocks rose Monday after news reports said Washington and Beijing are close to reaching an agreement as early as this month to end their costly tariff war. (AP Photo/Lee Jin-man)
March 04, 2019 - 10:06 am
NEW YORK (AP) — Investor hopes for a U.S.-China trade deal pushed stocks broadly higher in early trading Monday. The world's two largest economies have pulled back from an immediate escalation of their damaging trade war since they started negotiating last month. President Donald Trump postponed a...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 3:29 am
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology involving...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 1:49 am
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology involving...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 12:03 am
BEIJING (AP) — China has unveiled draft regulations on gene-editing and other potentially risky new biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology...
Read More
February 26, 2019 - 11:10 pm
BEIJING (AP) — China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically edited babies. That roiled the...
Read More

Pages